Search Results - "Massó, Elisabet"

Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines by Bover, Jordi, Massó, Elisabet, Gifre, Laia, Alfieri, Carlo, Soler-Majoral, Jordi, Fusaro, Maria, Calabia, Jordi, Rodríguez-Pena, Rosely, Rodríguez-Chitiva, Néstor, López-Báez, Víctor, Sánchez-Baya, Maya, da Silva, Iara, Aguilar, Armando, Bustos, Misael C, Rodrigues, Natacha, Chávez-Iñiguez, Jonathan S, Romero-González, Gregorio, Valdivielso, José Manuel, Molina, Pablo, Górriz, José L

“…Chronic kidney disease (CKD) is a highly prevalent condition worldwide in which the kidneys lose many abilities, such as the regulation of vitamin D (VD)…”
Get full text

The impact of COVID‐19 in hemodialysis patients: Experience in a hospital dialysis unit by Ibernon, Meritxell, Bueno, Isabel, Rodríguez‐Farré, Neus, Ruiz, Pilar, Sánchez, Ana, Massó, Elisabet, Rap, Oana, Giménez, Isabel, Cabrera, Cristina

“…Introduction COVID‐19 is a very high transmission disease with a variable prognosis in the general population. Patients in hemodialysis therapy are…”
Get full text

Vertebral fractures in patients with CKD and the general population: a call for diagnosis and action by Gifre, Laia, Massó, Elisabet, Fusaro, Maria, Haarhaus, Mathias, Ureña, Pablo, Cozzolino, Mario, Mazzaferro, Sandro, Calabia, Jordi, Peris, Pilar, Bover, Jordi

“…Vertebral fractures (VFs) are the most common osteoporotic fractures in the general population, and they have been associated with high mortality, decreased…”
Get full text

Sensitivity of blood volume monitoring for fluid status assessment in hemodialysis patients by Maduell, Francisco, Arias, Marta, Massó, Elisabet, Fontseré, Néstor, Carrera, Montserrat, Vera, Manel, Cases, Aleix, Campistol, Josep M

“…This study investigates the use of blood volume monitoring (BVM) markers for the assessment of fluid status. Predialysis fluid overload (FO) and BVM data were…”
Get more information

Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter by Lloret, Maria J, Fusaro, Maria, Jørgensen, Hanne S, Haarhaus, Mathias, Gifre, Laia, Alfieri, Carlo M, Massó, Elisabet, D'Marco, Luis, Evenepoel, Pieter, Bover, Jordi

“…Bone strength is determined not only by bone quantity [bone mineral density (BMD)] but also by bone quality, including matrix composition, collagen fiber…”
Get full text

Are Currently Used Bioimpedance Methods in Hemodialysis Comparable for Calculating Dialysis Dose? by Arias‐Guillén, Marta, Masso, Elisabet, Gomez, Miquel, Rodas, Lida, Broseta, Jose, Vera, Manel, Rios, Jose, Fontseré, Néstor, Maduell, Francisco

“…Bioelectrical impedance analysis has increasingly been incorporated into hemodialysis units (HD) as a useful, noninvasive technique for evaluating overall…”
Get full text

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1 by Martínez-Castelao, Alberto, Cases, Aleix, Carballada, Alberto Torre, Iranzo, Javier Torralba, Bronsoms, Josep, Vallès-Prats, Martí, Monserrat, Daniel Torán, Jimenez, Elisabet Masso

“…The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12g/dL, without intentionally exceeding 13g/dL during…”
Get full text

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study by Martínez-Castelao, Alberto, Cases, Aleix, Carballada, Alberto Torre, Iranzo, Javier Torralba, Bronsoms, Josep, Vallès-Prats, Martí, Monserrat, Daniel Torán, Jimenez, Elisabet Masso

“…The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12 g/dL, without intentionally exceeding 13 g/dL during…”
Get full text

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1 by Martínez-Castelao, Alberto, Cases, Aleix, Torre Carballada, Alberto, Torralba Iranzo, Javier, Bronsoms, Josep, Vallès-Prats, Martí, Torán Monserrat, Daniel, Masso Jimenez, Elisabet

“…Background and objective: The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12 g/dL, without intentionally…”
Get full text

Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease by Anguiano, Lidia, Riera, Marta, Pascual, Julio, Valdivielso, José Manuel, Barrios, Clara, Betriu, Angels, Mojal, Sergi, Fernández, Elvira, Soler, María José

“…Patients with cardiovascular (CV) disease have an increased circulating angiotensin-converting enzyme 2 (ACE2) activity, but there is little information about…”
Get full text

Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: the NEFRONA study by Arroyo, David, Betriu, Angels, Valls, Joan, Gorriz, Jose L, Pallares, Vicente, Abajo, Maria, Gracia, Marta, Valdivielso, Jose Manuel, Fernandez, Elvira

“…The ankle-brachial index (ABI) is widely used to diagnose subclinical peripheral artery disease (PAD) in the general population, but data assessing its…”
Get full text

Gender-specific risk factors and outcomes of hyperkalemia in CKD patients: smoking as a driver of hyperkalemia in men by Valdivielso, Jose M, Carriazo, Sol, Martin, Marisa, Fernandez-Fernandez, Beatriz, Bermudez-López, Marcelino, Ortiz, Alberto

“…Background Hyperkalemia is common among patients with chronic kidney disease (CKD) but there is scarce information on differential risk factors and outcomes…”
Get full text

Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease by Cambray, Serafi, Bermudez-Lopez, Marcelino, Bozic, Milica, Valdivielso, Jose M

“…Chronic kidney disease (CKD) is associated with an elevated risk of all-cause mortality, with cardiovascular death being extensively investigated. However,…”
Get full text

Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort by Valls, Joan, Cambray, Serafí, Pérez-Guallar, Carles, Bozic, Milica, Bermúdez-López, Marcelino, Fernández, Elvira, Betriu, Àngels, Rodríguez, Isabel, Valdivielso, José M

“…Chronic kidney disease (CKD) is a major risk factor for end-stage renal disease, cardiovascular disease and premature death. Despite classical clinical risk…”
Get full text

P1433VALIDATION OF A SERUM CALCIFICATION PROPENSITY TEST FOR THE PREDICTION OF ALL-CAUSE MORTALITY AMONG DIALYSIS PATIENTS by Ramos Sanchez, Rosa, Zawada, Adam, Wolf, Melanie, Rincon Bello, Abraham, Masso Jimenez, Elisabet, Hurtado Munoz, Sara, Ribera Tello, Laura, Mora-Macia, Josep, Stuard, Stefano, Stauss-Grabo, Manuela, Winter, Anke, Canaud, Bernard

“…Abstract Background and Aims Vascular calcification as cause of vascular stiffness is a major contributor to the high cardiac burden among stage 5 chronic…”
Get full text

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study by Martínez Castelao, Alberto, Cases Amenós, A. (Aleix), Torre Carballada, Alberto, Torralba Iranzo, Alberto, Bronsoms, Josep, Vallés Prat, Martí, Torán, Daniel, Masso Jimenez, Elisabet, Investigators of the ACERCA Study Group

“…BACKGROUND AND OBJECTIVE: The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12 g/dL, without intentionally…”
Get full text

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study by Martínez Castelao, Alberto, Cases Amenós, A. (Aleix), Torre Carballada, Alberto, Torralba Iranzo, Alberto, Bronsoms, Josep, Vallès Prats, Martí, Torán, Daniel, Masso Jimenez, Elisabet, Investigators of the ACERCA Study Group

“…BACKGROUND AND OBJECTIVE: The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12 g/dL, without intentionally…”
Get full text